Stürmer et al. respond to "propensity score methods in epidemiology"

American Journal of Epidemiology

Volumn 165, Issue 10, 2007, Pages 1122-1123

  Stürmer, Til ^a   Schneeweiss, Sebastian ^a,b   Rothman, Kenneth J ^a,c,d   Avorn, Jerry ^a   Glynn, Robert J ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

BODY MASS; COGNITION; DAILY LIFE ACTIVITY; DATA ANALYSIS; DRUG USE; HUMAN; MEDICAL INFORMATION; MORTALITY; NOTE; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; SMOKING; VALIDATION STUDY;

EID: 34547784109     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm068     Document Type: Note

References (13)

1. Oakes JM, Church TR. Invited commentary: advancing propensity score methods in epidemiology. Am J Epidemiol 2007;165:1119-21.
2. Stürmer T, Schneeweiss S, Rothman KJ, et al. Performance of propensity score calibration - a simulation study. Am J Epidemiol 2007;165:1110-18.
3. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc 1996;81:444-55.
4. Brookhart MA, Wang PS, Solomon DH, et al. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology 2006;17:268-75.
5. Glynn RJ. Commentary: genes as instruments for evaluation of markers and causes. Int J Epidemiol 2006;35:932-4.
6. Carroll RJ, Ruppert D, Stefanski LA. Measurement error in nonlinear models. London, United Kingdom: Chapman and Hall Ltd, 1995.
7. Buzas JS, Stefanski LA. Instrumental variable estimation in generalized linear measurement error models. J Am Stat Assoc 1996;91:999-1006.
8. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 2005;58:323-37.
9. Stürmer T, Schneeweiss S, Avorn J, et al. Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol 2005;162:279-89.
10. Stürmer T, Schneeweiss S, Rothman KJ, et al. Comparison of performance of propensity score calibration (PSC) and multiple imputation (MI) to control for unmeasured confounding using an internal validation study. (Abstract). Pharmacoepidemiol Drug Saf 2006;15(suppl):S39.
11. Schneeweiss S, Glynn RJ, Tsai EH, et al. Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology 2005;16:17-24.
12. Rosner B, Spiegelman D, Willett WC. Correction of logistic regression relative risk estimates and confidence intervals for measurement error: the case of multiple covariates measured with error. Am J Epidemiol 1990;132:734-45.
13. Glynn RJ, Schneeweiss S, Stürmer T. Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol 2006;98:253-9.